Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Boehringer Strikes Deal with Startup to Find Weight Loss Drug Targets

August 17, 2015 8:15 am | by Ryan Bushey, Associate Editor | News | Comments

The pharmaceutical giant's hope is that this partnership can generate an innovative drug that can broaden the company’s research and development efforts for cardiometabolic disease. Read more...


Study Reveals Benefits of Clinical Medication Reviews for Improving Medication Management

August 17, 2015 8:00 am | by Monash University | News | Comments

Structured and collaborative medication reviews performed by pharmacists and general practitioners are beneficial in improving the quality use of medicines. Read more...


International Team Discovers Ancient Origins of Deadly Lassa Virus

August 17, 2015 7:45 am | by The Scripps Research Institute | News | Comments

The Scripps Research Institute has published new findings showing the ancient roots of the deadly Lassa virus. Read more...


UN Official: Ebola Epidemic Could be Defeated by End of 2015

August 17, 2015 7:30 am | by Edith M. Lederer, Associated Press | News | Comments

The Ebola epidemic in West Africa can be defeated by the end of the year if the number of new cases drops to zero and stays at zero, the head of the World Health Organization said Thursday. Read more...


Capturing Cell Growth in 3-D

August 14, 2015 12:33 pm | by MIT News | News | Comments

Spinout’s microfluidics device better models how cancer and other cells interact in the body. Read more...


Yeast Engineered to Produce Opiates by Stanford Team

August 14, 2015 12:27 pm | by Seth Augenstein, Digital Reporter | News | Comments

Yeast has been used for centuries to make beer and wine. But now, through some major genetic engineering, the fungi have now been altered to produce opiates, according to a team of scientists. Read more...


Drug Discovery Spotlight: AstraZeneca-Inovio Cancer Vaccine Deal; Merck Job Cuts

August 14, 2015 12:06 pm | by Stephanie Guzowski, Editor | News | Comments

Your weekly roundup of news stories.


FDA Approves Oxycontin for Children 11 and Older

August 14, 2015 10:06 am | by Matthew Perrone, AP Health Writer | News | Comments

The Food and Drug Administration on Thursday approved the powerful painkiller OxyContin for a new use in children 11 to 16 who are suffering from severe, long-term pain. Read more...


Most Legionnaires' Deaths Tied to Spray From Shower, Faucet

August 14, 2015 10:00 am | by Mike Stobbe, AP Medical Writer | News | Comments

Most deaths from Legionnaires' disease are tied to hospital and nursing home showers, not outdoor cooling towers, new government figures released Thursday show. Read more...


Schizophrenia and Omega-3 Supplement Study Has “Enormous Potential,” Says NIMH Director

August 14, 2015 9:47 am | by Cynthia Fox, Science Editor | Articles | Comments

A mere 12 weeks of taking omega-3 fish oil capsules can ward off schizophrenia and other psychoses in at-risk children for 6.7 years, suggests a new Nature Communications paper. Of 41 at-risk young people taking three months of omega-3 supplements, most not only did not show severe functional impairment, but no longer experienced warning signs of psychosis, nearly seven years later. Read more...


Glaxo: Meds from Plant with Legionnaires' Bacteria are Safe

August 14, 2015 8:51 am | by Emery P. Dalesio, Associated Press | News | Comments

The London-based drug maker expects within three days it will reopen the manufacturing plant in Zebulon, about 25 miles east of Raleigh. Read more...


Hangovers Cost Australia $3B Each Year - But That Has Nothing on U.S. Drinkers

August 14, 2015 8:42 am | by Seth Augenstein, Digital Reporter | News | Comments

The time lost because of sick days and other time away from offices in Australia has nearly tripled since 2001. Read more...


Teva Announces FDA Acceptance of NDA for SD-809 for Huntington Disease Treatment

August 14, 2015 8:15 am | News | Comments

The NDA filing is based on positive results from two Phase 3 studies, FIRST-HD and ARC-HD. Read more...


Roche Buys GeneWEAVE to Boost Microbiology Diagnostics Offerings

August 14, 2015 8:00 am | News | Comments

The acquisition provides Roche with GeneWEAVE’s Smarticles technology.


Chemotherapy, Immune-Blocking Drug Combination Could Stop Cancer Growing Back

August 14, 2015 7:45 am | by Cancer Research UK | News | Comments

Clinical trials of patients are needed to confirm these early findings to see if the drug could help cancer patients after chemotherapy. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.